Navigation Links
Innovation Names Dr. Phil Samples Vice President, Government & Professional Services
Date:1/18/2013

JOHNSON CITY, N.Y., Jan. 18, 2013 /PRNewswire/ -- Innovation, makers of PharmASSIST® pharmacy automation solutions, today announced that Dr. Phil L. Samples has joined the firm as vice president, government & professional services. Dr. Samples will lead these respective functions with the goal of increasing Innovation's presence in the government pharmacy market and broadening the firm's professional consultative services offering.

(Logo: http://photos.prnewswire.com/prnh/20110719/NE37772LOGO )

Dr. Samples has over 30 years of pharmacy management, clinical pharmacy, and pharmacy benefits management in the federal government and retail pharmacy sectors. Prior to joining Innovation, Dr. Samples was a vice president for Truven Health Analytics, a leading provider of sophisticated healthcare analytics and extensive clinical referential services.

Dr. Samples retired in 2010, after 27 years of service, with the rank of colonel from the United States Air Force (USAF). He served as the tenth consultant for pharmacy services to the USAF Surgeon General and as a medical group commander (i.e., CEO) for hospitals within the United States and in the deployed environment. Dr. Samples was also lead coordinator for oversight and planning for Lean and Six Sigma initiatives and deployed to Southwest Asia (2009-10) as the expeditionary medical group commander.

Earlier in his career, Dr. Samples served as deputy command surgeon for the Air Force Materiel Command. In this role, he led all clinical oversight, strategic planning, and training of more than 6,300 medical personnel for the day-to-day delivery of healthcare in nine medical treatment facilities (MTFs) ranging from outpatient clinics to major teaching hospitals.

"Phil has a unique understanding of
'/>"/>

SOURCE Innovation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fogarty Institute for Innovation Accepting Applications for Advanced Endovascular Training Fellowship
2. Ansell y Comasec presentan Shared World of Innovation en ExpoProtection 2012
3. CardioMEMS, Inc. wins 2012 Intel Innovation Award
4. Vorsitzender & Managing Director von Glenmark Pharma - Herr Glenn Saldanha - erhielt Preis des Schweizer Botschafters für außergewöhnliche Innovation
5. PQ Bypass Graduates from the Fogarty Institute for Innovation, Establishes Independent Operations
6. Quebec Clinic Launches Canadian Use of Elektas Agility Beam-Shaping Innovation for Radiation Therapy of Cancer
7. Young Innovations Announces Definitive Agreement to be Acquired by Linden Capital Partners
8. Ansell and Comasec Unveil Shared World of Innovation at ExpoProtection 2012
9. Global Market for Medical Device Electrodes to Reach $1.43 billion, Technological Innovations and Developing Markets Fuel Demand for Neurological Monitoring and Digital Radiography
10. Philips Highlights Future Innovations at RSNA 2012 Transformation Lab
11. Israeli Innovation Shown to Demonstrate Reduction in Headaches and Neck Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  Surgical Theater, LLC announced today ... Business Advisory Board. New members include Ori ... Business Development and New Technologies for Given Imaging ... Senior Vice President and General Manager of Philips ... flight simulation technology to brain surgery and has ...
(Date:7/28/2014)... 2014  VigeneTech, Inc, in collaboration with BioLegend, ... Analysis Software, an OEM software solution for analysis ... and offers varieties of bead-based multi-analyte immunoassay products ... of VigeneTech,s data analysis software, FCS data files ... reported LEGENDplex™ software is a ...
(Date:7/28/2014)... July 28, 2014  Array BioPharma Inc. (Nasdaq: ... the fourth quarter and full year of ... to discuss those results on Tuesday, August ... and Michael Carruthers , Chief Financial ... August 12, 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) ...
Breaking Medicine Technology:Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... oncology: most, actively researched disease area Researchers ... reagent performance ... Strategic Diagnostics,Inc. (Nasdaq: SDIX ) -- today announced ... reagents in support of oncology-based research and,discovery. These high-quality ...
... FASgen,s fatty acid synthase,inhibitor (FASi) compounds, led ... xenograft cell line tested, in both orthotopic,and flank ... H1975; LX7); two,ovarian; breast; and, colon. In many ... been shown in extensive preclinical studies to,be remarkably ...
Cached Medicine Technology:Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog 2Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog 3Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog 4Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog 5FASgen Announces Significant Milestone in Its Cancer Drug Development Program 2
(Date:7/28/2014)... 2014 Parker Waichman LLP, a personal injury ... that the heroes of 9/11 are never forgotten, comments that ... important deadline. According to a VCF message dated ... cancer on or before October 12, 2012 must file a ... and others who were allegedly injured by the toxic dust ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... relieve sleep apnea in children, but a new study confirms ... if they,re already overweight. The researchers said that,s a ... of health problems -- including, ironically, sleep apnea. But they,re ... Instead, they said, doctors and parents should be aware that ...
(Date:7/28/2014)... Sarasota-based FCCI Insurance Group (FCCI) was recently ... Still headquartered in Sarasota where it was originally founded ... the top ten of the Best Large Companies category. ... August issue of Florida Trend magazine. One-hundred companies are ... #7 for 2014, FCCI has been in the top ...
(Date:7/28/2014)... for patients with one of the UK,s most common ... Chronic obstructive pulmonary disease (COPD) is the name for ... to long-term damage to the lungs. Often linked ... of all hospital admissions in the UK, with a ... they are discharged. , A team of ...
(Date:7/28/2014)... 2014 The report “Industrial Enzymes ... & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed), & ... defines and segments the global industrial enzymes market ... for industrial enzymes. It also identifies driving and ... with analysis of trends, opportunities, burning issues, winning ...
Breaking Medicine News(10 mins):Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 2Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 3Health News:FCCI Insurance Group Makes Top 100 Best Companies List – and is the Only Florida-Headquartered Company in Top Ten 2Health News:FCCI Insurance Group Makes Top 100 Best Companies List – and is the Only Florida-Headquartered Company in Top Ten 3Health News:New research to tackle treatment for lung disease 2Health News:New research to tackle treatment for lung disease 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 4
... Tenn., Nov. 2 Brookdale Senior Living Inc. (NYSE: ... for the third quarter of 2009. , Bill ... results this quarter which build on the success of the ... operating effectively in today,s difficult environment as evidenced by our ...
... FDA NOTE TO CORRESPONDENTS , SILVER SPRING, ... Administration (FDA) today released a listing of eight recent ... products. These updates can be accessed from the agency,s ... You can sign-up for e-mail notices of new ...
... Nov. 2 The Ensign Group, Inc. (Nasdaq: ENSG ... nursing, rehabilitative care services, hospice care and assisted living companies, ... year 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , ... , Total revenue was a record $132.9 million, up ...
... Highest Levels of BPA Were Detected in Some Samples of Green ... Levels Shown to Cause Harm in Animal Studies; FDA,s Safety Standards ... 2 Consumer Reports, latest tests of canned foods, including ... of the 19 name-brand foods tested contain measurable levels of Bisphenol ...
... patients with HER2 positive tumors one centimeter or smaller are ... those with early-stage disease who do not express the aggressive ... University of Texas M. D. Anderson Cancer Center. The ... Oncology , is the first large study to analyze this ...
... who received influenza vaccine during pregnancy were hospitalized at ... according to preliminary results of an ongoing study by ... the study October 29 at the 47th annual meeting ... Influenza is a major cause of serious ...
Cached Medicine News:Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 2Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 3Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 4Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 5Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 6Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 7Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 8Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 9Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 10Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 11Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 12Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 13Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 14Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 15Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 16Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 17Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 18Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 19Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 20Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 21Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 22Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 23Health News:FDA CONSUMER HEALTH INFORMATION UPDATES: Fraudulent H1N1 flu products, hearing aids, sound amplifiers, tobacco regulation, FDA's international posts, LASIK eye surgery, and FDA MedWatch safety alerts 2Health News:FDA CONSUMER HEALTH INFORMATION UPDATES: Fraudulent H1N1 flu products, hearing aids, sound amplifiers, tobacco regulation, FDA's international posts, LASIK eye surgery, and FDA MedWatch safety alerts 3Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 2Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 3Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 4Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 5Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 6Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 7Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 8Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 9Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 10Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 11Health News:The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share 12
... Pectoralis Implants come in three styles. ... is by far the most popular style. ... and are packaged and sold individually, not ... that they are each made for a ...
... In vivo results may be affected by the ... scar tissue can impact the desired augment-ation 1 ... from patient to patient. Implant dimensions can be ... surgical scissors. All dimensions in centimeters. This device ...
... in the IQmark family elevates your ECG and ... portability, cost-savings and efficient patient care. The IQmark ... the office, clinics and medical centers as well ... used in conjunction with the IQmark Digital ECG ...
24-hour full disclosure , Input range: 5mV , Analog bandwidth: 0.05 to 100Hz (3dB) , Common mode rejection ratio: 60dB , Dimensions: 4.46in. x 2.75in. x 1.02in. (113mm x 70mm x 26mm) , We...
Medicine Products: